We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Doximity, Inc. is one of them.
Doximity, Inc. (NYSE:DOCS) remains a leading healthcare technology stock, leveraging AI-driven tools and strategic acquisitions to strengthen its position in the medical sector. The company operates a cloud-based professional network for U.S. clinicians, offering secure telemedicine, collaboration, and workflow solutions.
Recently, DOCS completed the acquisition of Pathway Medical, an AI-powered clinical reference platform. The integration enhances Doximity’s flagship DoxGPT tool, providing instant, verified access to medical data, peer-reviewed research, and context-aware AI responses within daily clinical workflows. Pathway’s AI model scored 96% on the U.S. Medical Licensing Exam benchmark, underscoring the corporation’s commitment to clinical quality and innovation.
DOCS also expanded its offerings with Doximity Scribe, a free ambient AI scribe that automates clinical documentation and reduces after-hours administrative work.
Doximity, Inc.’s last quarter, ending June 30, 2025, saw revenue climb 15% year-over-year, reaching $145.9 million, which exceeded analyst forecasts. The company delivered non-GAAP earnings per share (EPS) of $0.36. User engagement and product adoption surged, especially in new AI scribe and workflow tools.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW
